0001189727-18-000012.txt : 20180621 0001189727-18-000012.hdr.sgml : 20180621 20180621182542 ACCESSION NUMBER: 0001189727-18-000012 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180621 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BURCAR ALISON D CENTRAL INDEX KEY: 0001189727 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 18912770 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL INC STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FORMER NAME: FORMER CONFORMED NAME: BRUMMETT BURCAR ALISON DATE OF NAME CHANGE: 20020916 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2018-06-21 0 0000883984 ICU MEDICAL INC/DE ICUI 0001189727 BURCAR ALISON D 951 CALLE AMANECER SAN CLEMENTE CA 92673 0 1 0 0 Vice President and Gen'l Mgr. Common Stock 2018-06-21 4 X 0 13219 88.76 A 13219 D Common Stock 2018-06-21 4 X 0 1976 58.79 A 15195 D Common Stock 2018-06-21 4 S 0 3320 295.27 D 11875 D Common Stock 2018-06-21 4 S 0 4704 296.34 D 7171 D Common Stock 2018-06-21 4 S 0 5502 297.38 D 1669 D Common Stock 2018-06-21 4 S 0 1412 298.24 D 257 D Common Stock 2018-06-21 4 S 0 257 301.12 D 0 D Non-Qualified Stock Option (right to buy) 58.79 2018-06-21 4 X 0 1976 0.0 D 2024-02-24 Common Stock 1976 0 D Non-Qualified Stock Option (right to buy) 88.76 2018-06-21 4 X 0 13219 0.0 D 2025-02-11 Common Stock 13219 0 D The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Options exercisable in four equal annual cumulative installments commencing one year after the grant date. Transaction is the exercise of a derivative security; see Column 2. Options exercisable one-third annually over the first three anniversaries of the grant date. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2018. By: Alejandro Parras, Attorney-In-Fact For: Alison Burcar 2018-06-21